Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Handel & varor |
| Industri | Dagligvaror |
2024-03-21 13:03:12
21 March 2024: Aker BioMarine ASA has published its annual financial statements
in European
Single Electronic Format (ESEF), available as an attachment to this release.
Correction: New version enclosed due to an incorrect file name of
the file containing the annual financial statements in European Single
Electronic Format (ESEF) published yesterday at 08:00 CET.
For further information, please contact
Christopher Robin Vinter, VP IR & Corporate Finance
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com
This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.
About Aker BioMarine
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting
company developing krill-derived products for consumer health and wellness as
well as animal nutrition. The company has a strong position in its industry and
is the world's leading supplier of krill, the natural, powerful and health
promoting source of nutrients from the pristine waters of Antarctica. Aker
BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available
at www.akerbiomarine.com.